10.1111/j.1476-5381.2009.00441.x [DOI] [PMC free article] [PubMed] [Google Scholar] Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, Kuchibhotla U, Moyers JS, Benson CT, Gimeno RE, DAlessio DA, Haupt A (2018) LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept
The guidelines are based on extensive research and testing, reflecting the importance of maintaining the integrity of the medication
Injecting on a very full stomach may increase nausea risk
Do not stop taking Ozempic without consulting your healthcare provider
Plus, they can be expensive and require a prescription